DORM Q1 2026 Earnings EPS Misses Estimates Stock Under Pressure KULR Q3 2025 Earnings Deep Losses Miss Estimates Despite Stock Surge DPRO Q1 2026 Earnings WiderthanExpected Loss No Revenue Reported Stock Gains 288 Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses BIP Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds FTI Consulting FCN Q1 2026 Earnings EPS Misses Estimates but Stock Gains